2021 AHPBA指南:胰腺手术中VTE预防和抗凝管理

2021-12-20 美国肝胰胆协会 HPB (Oxford)

2021年12月,美国肝胰胆协会(AHPBA)发布了胰腺手术中VTE预防和抗凝管理指南。腹部大手术和恶性肿瘤导致高凝状态,胰腺手术后发生静脉血栓塞(VTE)的风险约为3%。

中文标题:

2021 AHPBA指南:胰腺手术中VTE预防和抗凝管理

英文标题:

AHPBA guidelines for managing VTE prophylaxis and anticoagulation for pancreatic surgery

发布机构:

美国肝胰胆协会

发布日期:

2021-12-20

简要介绍:

2021年12月,美国肝胰胆协会(AHPBA)发布了胰腺手术中VTE预防和抗凝管理指南。腹部大手术和恶性肿瘤导致高凝状态,胰腺手术后发生静脉血栓塞(VTE)的风险约为3%。本文主要针对胰腺手术中VTE预防和抗凝管理提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AHPBA指南:胰腺手术中VTE预防和抗凝管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=dd4081c002339646, title=2021 AHPBA指南:胰腺手术中VTE预防和抗凝管理, enTitle=AHPBA guidelines for managing VTE prophylaxis and anticoagulation for pancreatic surgery, guiderFrom=HPB (Oxford), authorId=0, author=, summary=2021年12月,美国肝胰胆协会(AHPBA)发布了胰腺手术中VTE预防和抗凝管理指南。腹部大手术和恶性肿瘤导致高凝状态,胰腺手术后发生静脉血栓塞(VTE)的风险约为3%。, cover=https://img.medsci.cn/2022125/1643110723510_1608702.png, journalId=0, articlesId=null, associationId=506, associationName=美国肝胰胆协会, associationIntro=美洲肝胰胆协会(AHPBA)是为国际肝胰胆协会(IHPBA)美国分部。IHPBA正式成立第一届大会于1994年5月31日在波士顿,马萨诸塞州。AHPBA落成于1994年11月12日在芝加哥,伊利诺斯。旨在促进对肝胰胆疾病病因及治疗的认识,加深外科医生与肝病科、消化科医生的知识交流。, copyright=0, guiderPublishedTime=Mon Dec 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月,美国肝胰胆协会(AHPBA)发布了胰腺手术中VTE预防和抗凝管理指南。腹部大手术和恶性肿瘤导致高凝状态,胰腺手术后发生静脉血栓塞(VTE)的风险约为3%。本文主要针对胰腺手术中VTE预防和抗凝管理提供指导建议。</span></p>, tagList=[TagDto(tagId=83039, tagName=胰腺手术), TagDto(tagId=90962, tagName=抗凝管理), TagDto(tagId=122204, tagName=VTE预防)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3817, appHits=65, showAppHits=0, pcHits=293, showPcHits=3752, likes=0, shares=19, comments=3, approvalStatus=1, publishedTime=Wed Jan 26 15:36:00 CST 2022, publishedTimeString=2021-12-20, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=dajiong, createdTime=Tue Jan 25 19:42:03 CST 2022, updatedBy=6415643, updatedName=凯晨, updatedTime=Thu Jan 04 07:19:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHPBA指南:胰腺手术中VTE预防和抗凝管理.pdf)])
2021 AHPBA指南:胰腺手术中VTE预防和抗凝管理.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220327, encodeId=43fb122032e65, content=<a href='/topic/show?id=4a481855350' target=_blank style='color:#2F92EE;'>#VTE#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18553, encryptionId=4a481855350, topicName=VTE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:14:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188364, encodeId=724b118836469, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a72531166, createdName=125008a0m23暂无昵称, createdTime=Wed Jan 26 18:05:33 CST 2022, time=2022-01-26, status=1, ipAttribution=)]
    2022-05-17 赛华佗
  2. [GetPortalCommentsPageByObjectIdResponse(id=1220327, encodeId=43fb122032e65, content=<a href='/topic/show?id=4a481855350' target=_blank style='color:#2F92EE;'>#VTE#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18553, encryptionId=4a481855350, topicName=VTE)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:14:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188364, encodeId=724b118836469, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a72531166, createdName=125008a0m23暂无昵称, createdTime=Wed Jan 26 18:05:33 CST 2022, time=2022-01-26, status=1, ipAttribution=)]
    2022-01-26 125008a0m23暂无昵称

    0